Evidence map›Paper›PMID 34206090›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Exposure to TiO

Sarah A Valentino, Laëtitia Chézeau, Carole Seidel, Sylvie Sébillaud, Mylène Lorcin, Monique Chalansonnet, Frédéric Cosnier, Laurent Gaté

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sarah A ValentinoInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.
Laëtitia ChézeauInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.
Carole SeidelInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.
Sylvie SébillaudInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.
Mylène LorcinInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.
Monique ChalansonnetInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.
Frédéric CosnierInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.ORCID 0000-0002-8596-927X
Laurent GatéInstitut National de Recherche et de Sécurité, 1 rue du Morvan, 54510 Vandoeuvre-lès-Nancy, France.ORCID 0000-0001-5629-7390
Institut National de Recherche et de Sécurité · FR

Funding

Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail N/AHorizon 2020 Framework Programme 686098
6 · The paper itself

Abstract

Although aging is associated with a higher risk of developing respiratory pathologies, very few studies have assessed the impact of age on the adverse effects of inhaled nanoparticles. Using conventional and transcriptomic approaches, this study aimed to compare in young (12-13-week-old) and elderly (19-month-old) fisher F344 rats the pulmonary toxicity of an inhaled nanostructured aerosol of titanium dioxide (TiO

Indexed as

ageinhalationlungrattitanium dioxidetranscriptomics

Identifiers

PMID34206090
PMCPMC8230065
OpenAlexW3171531756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.